Anti-PD-1 therapy combined with chemotherapy in patients with advanced biliary tract cancer

被引：0
|
作者：
Danyang Sun
Junxun Ma
Jinliang Wang
Chun Han
Yuanyu Qian
Guangying Chen
Xiaoyan Li
Juan Zhang
Pengfei Cui
Wushuang Du
Zhaozhen Wu
Shixue Chen
Xuan Zheng
Zhichao Yue
Jia Song
Chan Gao
Xiaochen Zhao
Shangli Cai
Yi Hu
机构：
[1] Chinese People’s Liberation Army General Hospital,Department of Medical Oncology
[2] 3D Medicines Inc.,The Medical Department
来源：
Cancer Immunology, Immunotherapy | 2019年 / 68卷
关键词：
Biliary tract cancer; PD-1 inhibitors; Combination therapy; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1527 / 1535
页数：8
相关论文
共 50 条
  • [21] EFFECT OF COMBINED ANTI-PD-1 AND TEMOZOLOMIDE THERAPY IN GLIOBLASTOMA
    Park, Junseong
    Kim, Chang Gon
    Lee, Jae Eun
    Shim, Jin-Kyoung
    Kim, Eui Hyun
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    [J]. NEURO-ONCOLOGY, 2018, 20 : 123 - 124
  • [22] Local therapy combined with anti-PD-1 immunotherapy for advanced lung adenocarcinoma: A case report
    Wu, Na
    Yang, Xiaoxin
    Zhai, Yan
    Lu, Wei
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (02) : 739 - 744
  • [23] Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
    Park, Junseong
    Kim, Chang Gon
    Shim, Jin-Kyoung
    Kim, Jong Hoon
    Lee, Hoyoung
    Lee, Jae Eun
    Kim, Min Hwan
    Haam, Keeok
    Jung, Inkyung
    Park, Su-Hyung
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    [J]. ONCOIMMUNOLOGY, 2019, 8 (01):
  • [24] A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer
    Sun, Danyang
    Ma, Junxun
    Wang, Jinliang
    Wang, Lijie
    Zhang, Sujie
    Chen, Guangying
    Li, Xiaoyan
    Cui, Pengfei
    Zheng, Xuan
    Hu, Yi
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1421 - +
  • [25] Anti-PD-1 combined with targeted therapy: Theory and practice in gastric and colorectal cancer
    Chen, Yao
    Bai, Bingjun
    Ying, Kangkang
    Pan, Hongming
    Xie, Binbin
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2022, 1877 (05):
  • [26] Efficacy of Programmatic Combined Stereotactic Ablative Radiotherapy and Anti-PD-1 Therapy in Advanced Lung Cancer: A Retrospective Analysis
    Hegde, A.
    Cherry, C.
    Stroud, G.
    Pinnamaneni, R.
    Cherukuri, S.
    Bowling, M.
    Arastu, H.
    Walker, P. R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1556 - S1557
  • [27] Factors Influencing the Efficacy of Anti-PD-1 Therapy in Chinese Patients with Advanced Melanoma
    Zhao, Lingdi
    Yang, Yonghao
    Ma, Baozhen
    Li, Wei
    Li, Tiepeng
    Han, Lu
    Zhang, Yong
    Shang, Yi-Man
    Lin, Hongwei
    Gao, Quanli
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [28] Early salvage therapy with anti-PD-1 antibody Camrelizumab in patients with advanced cervical cancer: a retrospective study
    Jian, Xianglin
    Zhang, Jiajing
    Huang, Ying
    Duan, Jingya
    Linghu, Hua
    Li, Ruonan
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2024,
  • [29] Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer
    Tan, Yang
    Liu, Kai
    Zhu, Chengpei
    Wang, Shanshan
    Wang, Yunchao
    Xue, Jingnan
    Ning, Cong
    Zhang, Nan
    Chao, Jiashuo
    Zhang, Longhao
    Long, Junyu
    Yang, Xiaobo
    Zeng, Daobing
    Zhao, Lijin
    Zhao, Haitao
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (12)
  • [30] The predictive value of PD-L1 expression in response to anti-PD-1/PD-L1 therapy for biliary tract cancer: a systematic review and meta-analysis
    Yoon, Seung Bae
    Woo, Sang Myung
    Chun, Jung Won
    Kim, Dong Uk
    Kim, Jaihwan
    Park, Joo Kyung
    So, Hoonsub
    Chung, Moon Jae
    Cho, In Rae
    Heo, Jun
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
12345